Physician profile
Rick L Bennett
NPI 1528005667
$1,217.06
in general payments reported to CMS, 2019-2025
23 companies · $31.34 in 2025
The $31.34 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $137 · 2020: $172 · 2021: $75.02 · 2022: $231 · 2023: $359 · 2024: $212 · 2025: $31.34.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $602.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $602.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $195.04 | 2022-2024 | Ozempic, Rybelsus |
| Amgen INC. | $150.06 | 2022-2024 | Repatha, Otezla |
| Boston Scientific Corporation | $147.76 | 2020-2023 | |
| Janssen Pharmaceuticals, INC | $81.25 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $60.88 | 2023-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $53.52 | 2023-2024 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $46.53 | 2019-2021 | |
| Shockwave Medical, INC | $46.15 | 2022 | |
| Pfizer INC. | $43.46 | 2019-2020 | |
| Inspire Medical Systems, INC. | $42.23 | 2023 | Inspire |
| Regeneron Healthcare Solutions, INC. | $41.74 | 2019 | |
| Sanofi-Aventis U.S. LLC | $37.15 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $34.06 | 2019-2023 | Camzyos |
| Teleflex LLC | $31.58 | 2022 | |
| Philips North America LLC | $31.58 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $31.34 | 2025 | Cologuard Collection Kit |
| Novartis Pharmaceuticals Corporation | $25.12 | 2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $24.57 | 2023 | Lifevest |
| Abbott Laboratories | $22.79 | 2023 | Architect |
| Esperion Therapeutics, INC. | $20.00 | 2020 | |
| Shield Therapeutics INC | $18.49 | 2023 | Accrufer |
| Chiesi USA, INC. | $15.94 | 2024 | Cleviprex, Kengreal |
| Nestle Healthcare Nutrition INC. | $15.82 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rick Bennett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.